Redmile Group, LLC's Form 4 filing
ADC Therapeutics SA (ADCT) · filed Apr 2, 2026
- Accession no.
- 0001104659-26-039359
- Filed
- Apr 2, 2026, 9:00 PM ET
- Trade date
- Mar 31-Apr 2, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $19.6M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Redmile Group, LLCCIK 0001425738 | 10% Owner |
| Green JeremyCIK 0001650527 | 10% Owner |
| RedCo II Master Fund, L.P.CIK 0001921783 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | SSaleDisposed | −196,229 | $3.75 | −$736,251.21 | 15,470,502 | Indirect | |
| Mar 31, 2026 | Common Stock | SSaleDisposed | −188,407 | $3.75 | −$706,903.06 | 12,957,305 | Direct | |
| Apr 1, 2026 | Common Stock | SSaleDisposed | −169,265 | $3.80 | −$643,037.74 | 15,301,237 | Indirect | |
| Apr 1, 2026 | Common Stock | SSaleDisposed | −162,517 | $3.80 | −$617,402.08 | 12,794,788 | Direct | |
| Apr 2, 2026 | Common Stock | SSaleDisposed | −2,634,506 | $3.28 | −$8,638,545.17 | 12,666,731 | Indirect | |
| Apr 2, 2026 | Common Stock | SSaleDisposed | −2,529,491 | $3.28 | −$8,294,200.99 | 10,265,297 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.